Mature B-Cell Non-Hodgkin Lymphoma — Trials

Mature B-Cell Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

2,506 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 792
Recruiting: 402
Ph III recruiting: 40
Growth YoY: +9.6%
Industry share: 24%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (393)

clinicaltrialsPublishedShowing 451–473 of 473 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00275431	Phase II Safety and Efficacy Study of Single-agent AT-101 in Patients With Relapsed or Refractory B-cell Malignancies	completed	Phase 2	50	Ascenta TherapeuticsINDUSTRY	1	Jun 29, 2011	clinicaltrials
NCT00142129	Bortezomib (Velcade) in Waldenstrom's Macroglobulinemia	completed	Phase 2	27	Dana-Farber Cancer InstituteOTHER	1	Jun 27, 2011	clinicaltrials